twitter twitter

Bio Ascend

Early-Bird Rates Available through September 26, 2024

Early-Bird Rates Available through September 26, 2024

17th Atlanta Lung Cancer Symposium Agenda

2024 Agenda Coming Soon!

Those with approved access can enter their access code. 

Please be advised that only paid registrants and attendees of of this symposium will be provided access to this downloadable content.

Saturday, October 28, 2023

7:00 AM
Breakfast Symposium
7:55 AM
Welcome and Introductions
Suresh Ramalingam, MD, FACP, FASCO
Kristin Higgins, MD
Ticiana A. Leal, MD

Plenary 1: Early-Stage NSCLC

Co-Chairs: Ticiana Leal, MD, and Ioana Bonta, MD

8:00 AM
Perioperative Immunotherapy in NSCLC
Tina Cascone, MD, PhD

8:20 AM

Surgical Considerations in Neoadjuvant Immunotherapy in NSCLC
Felix G. Fernandez, MD, MSc
8:40 AM
Adjuvant TKI Therapy in NSCLC
Gregory Riely, MD, PhD

8:55 AM

Role of RT in Early-Stage NSCLC
Kristin Higgins, MD

9:15 AM

Use of ctDNA in Early-Stage NSCLC
Valsamo Anagnostou, MD, PhD

9:35 AM

Panel Discussion

9:55 AM

Morning Break and Exhibits

Plenary 2: Unresectable Locally Advanced NSCLC/Oligometastatic NSCLC

Co-Chairs: Mohan Krishnamachary, MD, and Kristin Higgins, MD

10:15 AM

Beyond PACIFIC in Stage III NSCLC
Ticiana Leal, MD

10:35 AM

Consolidation RT in Oligometastatic NSCLC
Sibo Tian, MD

10:55 AM

DEBATE: Targeted Therapy in Stage III NSCLC – Yes or No?
Yes: Jyoti D. Patel, MD
No: Stephen Liu, MD

11:35 AM

Panel Discussion

11:55 AM

Lunch Symposium

Plenary 3: Immunotherapy in Advanced NSCLC

Co-Chairs: William Jonas, MD, and Jennifer Carlisle, MD

12:45 PM

Updates in Frontline Immunotherapy in NSCLC
Paul Bunn, MD

1:05 PM

Emerging Strategies in IO-Resistant NSCLC
Ticiana Leal, MD

1:25 PM

Novel Treatment Approaches in SCLC

Taofeek Owonikoko, MD, PhD

1:45 PM

Panel Discussion

2:05 PM

Afternoon Break and Exhibits

Plenary 4: Targeted Therapies in Advanced NSCLC

Co-Chairs: Paul Gill, MD, and Michael Andrews, MD

2:25 PM

Updates in EGFR NSCLC

Suresh Ramalingam, MD, FACP, FASCO

2:40 PM

EGFR Exon 20 and EGFR Uncommon Mutations in NSCLC

Jennifer W. Carlisle, MD

2:55 PM

KRAS NSCLC and Combinations to Overcome Resistance

John V. Heymach, MD, PhD

3:10 PM

ALK/HER2 NSCLC

Conor E. Steuer, MD

3:25 PM

BRAF/RET/MET NSCLC

Ibiayi Dagogo-Jack, MD

3:40 PM

Panel Discussion

3:55 PM

Closing Remarks and Adjourn

We use cookies for various purposes including enabling website functionality and targeted marketing activities. For more information about cookies, please review our Privacy & Cookie Notice.